Quarterly Financial Data (Unaudited and restated) - Restated consolidated balance sheet (Details) - USD ($)	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill	$ 3,301,959	$ 3,214,747			$ 1,452,338
Total Assets	104,396,912	119,911,913		$ 120,961,233
Deferred tax liability			$ 215,937	215,937
Total Liabilities	31,960,244	33,713,188	33,141,130	8,927,662
Accumulated deficit	209,153,659	(193,929,176)	(180,670,826)	165,718,953
Total Stockholders' Equity - NightHawk Biosciences, Inc.	73,922,847	87,538,725	99,964,241	113,108,314
Total Stockholders' Equity	$ 72,436,668	86,198,726	98,713,663	$ 112,033,571	$ 115,493,923
As Previously Reported
Goodwill		3,467,747
Total Assets		120,164,913
Deferred tax liability		3,326,000	3,541,937
Total Liabilities		37,039,188	36,467,130
Accumulated deficit		(197,002,176)	(183,996,826)
Total Stockholders' Equity - NightHawk Biosciences, Inc.		84,465,725	96,638,241
Total Stockholders' Equity		83,125,726	95,387,663
Adjustments
Goodwill		(253,000)
Total Assets		(253,000)
Deferred tax liability		(3,326,000)	(3,326,000)
Total Liabilities		(3,326,000)	(3,326,000)
Accumulated deficit		3,073,000	3,326,000
Total Stockholders' Equity - NightHawk Biosciences, Inc.		3,073,000	3,326,000
Total Stockholders' Equity		$ 3,073,000	$ 3,326,000